[Clinical and immunological aspects of the Schoenlein-Henoch syndrome].
D000368:Aged; D000493:Allopurinol / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D002648:Child; D005260:Female; D005921:Glomerulonephritis / Q000209:etiology; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000276:immunology; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007668:Kidney / Q000276:immunology / Q000473:pathology; D008297:Male; D009404:Nephrotic Syndrome / Q000209:etiology; D011693:Purpura / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D012867:Skin / Q000473:pathology
D000970:Antineoplastic Agents; D001323:Autoantibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D000493:Allopurinol
Klinik und Immunologie des Schoenlein-Henoch-Syndroms